Oxford Immunotec (OXFD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 11,788 | 12,274 | 10,225 | 10,726 | 10,154 |
| Cost of Goods | 5,993 | 6,012 | 4,435 | 4,931 | 4,867 |
| Gross Profit | 5,795 | 6,262 | 5,790 | 5,795 | 5,287 |
| Operating Expenses | 12,819 | 9,213 | 8,373 | 8,919 | 6,869 |
| Operating Income | -6,031 | -2,939 | -2,148 | -2,193 | -715 |
| Interest Expense | 0 | 0 | 289 | 0 | 0 |
| Other Income | -209 | -182 | -834 | -973 | -229 |
| Pre-tax Income | -6,240 | -3,121 | -3,271 | -3,166 | -944 |
| Income Tax | -6 | 32 | 57 | 15 | 10 |
| Net Income Continuous | -6,234 | -3,153 | -3,328 | -3,181 | -954 |
| Net Income | $-6,234 | $-3,153 | $-3,328 | $-3,181 | $-954 |
| EPS Basic Total Ops | -0.36 | -0.18 | 0.08 | -1.36 | -0.42 |
| EPS Basic Continuous Ops | -0.36 | -0.18 | 0.08 | -1.36 | -0.42 |
| EPS Diluted Total Ops | -0.36 | -0.18 | 0.08 | -1.36 | -0.42 |
| EPS Diluted Continuous Ops | -0.36 | -0.18 | 0.08 | -1.36 | -0.42 |
| EBITDA(a) | $-5,622 | $-2,588 | $-1,910 | $-1,887 | $-453 |